{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:46:34Z","timestamp":1762865194175},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1996,2]]},"DOI":"10.1007\/bf02529727","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T07:04:30Z","timestamp":1165993470000},"page":"73-80","source":"Crossref","is-referenced-by-count":91,"title":["A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica"],"prefix":"10.1007","volume":"58","author":[{"given":"J. H.","family":"Healey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Paget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Williams-Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. P.","family":"Szatrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Spiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mitnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schwartzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02529727_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2796.1993.tb00738.x","volume":"234","author":"T Olbricht","year":"1993","unstructured":"Olbricht T, Benker G (1993) Glucocorticoid-induced osteoporosis: pathogenesis, prevention, and treatment, with special regard to the rheumatic diseases. J Int Med 234:237\u2013244","journal-title":"J Int Med"},{"key":"BF02529727_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-112-5-352","volume":"112","author":"BP Lukert","year":"1990","unstructured":"Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 112:352\u2013364","journal-title":"Ann Int Med"},{"key":"BF02529727_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0049-0172(05)80029-0","volume":"22","author":"JD Adachi","year":"1993","unstructured":"Adachi JD, Bensen WG, Hodsman AB (1993) Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 22:375\u2013384","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl A","key":"BF02529727_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0954-6111(05)80252-5","volume":"87","author":"DJ Hosking","year":"1993","unstructured":"Hosking DJ (1993) Effects of corticosteroid on bone turnover. Respir Med 87 (suppl A):15\u201320","journal-title":"Respir Med"},{"key":"BF02529727_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00001433-199410000-00006","volume":"5","author":"JH Healey","year":"1994","unstructured":"Healey JH (1994) Glucocorticoid-induced osteoporosis. Curr Opinions Orthop 5:33\u201338","journal-title":"Curr Opinions Orthop"},{"key":"BF02529727_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0049-0172(91)90021-Q","volume":"20","author":"I Joffe","year":"1991","unstructured":"Joffe I, Epstein S (1991) Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 20:256\u2013272","journal-title":"Semin Arthritis Rheum"},{"key":"BF02529727_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780280402","volume":"28","author":"TR Dykman","year":"1995","unstructured":"Dykman TR, Gluck OS, Murphy WA, Han TJ, Han BH (1995) Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatoid arthritis. Arthritis Rheum 28:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"BF02529727_CR8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1001\/archinte.1990.00390230093012","volume":"150","author":"IR Reid","year":"1990","unstructured":"Reid IR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving chronic glucocorticoid therapy. Arch Int Med 150:2545\u20132548","journal-title":"Arch Int Med"},{"key":"BF02529727_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(88)92721-3","volume":"1","author":"IR Reid","year":"1988","unstructured":"Reid IR, King AR, Alexander CJ, Ibbertson HK (1988) Prevention of steroid-induced osteoporosis with 3-amino-1-hydropropylidene 1, 1-bisphosphonate (ADP). Lancet 1:143\u2013146","journal-title":"Lancet"},{"key":"BF02529727_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02565124","volume":"49","author":"L Montemurro","year":"1991","unstructured":"Montemurro L, Schiraldi G, Fraioli P (1991) Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 49:71\u201376","journal-title":"Calcif Tissue Int"},{"key":"BF02529727_CR11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/gut.34.11.1543","volume":"34","author":"D Clements","year":"1993","unstructured":"Clements D, Compston JE, Evans WD, Rhodes J (1993) Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 34:1543\u20131546","journal-title":"Gut"},{"key":"BF02529727_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198308043090502","volume":"309","author":"AD Adinoff","year":"1983","unstructured":"Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309: 265\u2013268","journal-title":"N Engl J Med"},{"key":"BF02529727_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02411257","volume":"34","author":"V LoCascio","year":"1982","unstructured":"LoCascio V, Adzmi S, Avioli LL, et al (1982) Suppressive effect of chronic glucocorticoid treatment of circulating calcitonin in man. Calcif Tissue Int 34:309\u2013310","journal-title":"Calcif Tissue Int"},{"key":"BF02529727_CR14","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/0002-9343(93)90382-Y","volume":"95","author":"JY Reginster","year":"1993","unstructured":"Reginster JY (1993) Calcitonin for prevention and treatment of osteoporosis. Am J Med 95:44S-47S","journal-title":"Am J Med"},{"key":"BF02529727_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0026-0495(84)90187-2","volume":"33","author":"HE Gruber","year":"1984","unstructured":"Gruber HE, Ivey JL, Baylink DJ (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295\u2013303","journal-title":"Metabolism"},{"key":"BF02529727_CR16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","volume":"305","author":"K Overgaard","year":"1992","unstructured":"Overgaard K, Hansen MA, Jensen SB, Cristiansen C (1992) Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study. Br Med J 305:556\u2013561","journal-title":"Br Med J"},{"key":"BF02529727_CR17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(88)91712-6","volume":"1","author":"I MacIntyre","year":"1988","unstructured":"MacIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Healy MJR (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet 1:900\u2013902","journal-title":"Lancet"},{"key":"BF02529727_CR18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, et al (1990) The American College of Rheumatology Criteria for the Classification of Giant Cell Arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"BF02529727_CR19","first-page":"76","volume-title":"Primer on the rheumatic disease","author":"GP Rodman","year":"1983","unstructured":"Rodman GP, Schumacher R (1983) Polymyalgia rheumatica and temporal arteritis. In: Primer on the rheumatic disease, 8th ed. Arthritis Foundation. Atlanta, GA, pp 76\u201377","edition":"8th ed."},{"key":"BF02529727_CR20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"TY Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland GT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97:672\u2013680","journal-title":"Ann Intern Med"},{"key":"BF02529727_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jor.1100130213","volume":"13","author":"PG Williams-Russo","year":"1995","unstructured":"Williams-Russo PG, Healey JH, Szatrowski TP, Schneider R, Paget S, Ales K, Schwartzberg P (1995) Clinical reproducibility of dual energy X-ray absorptiometry. J Orthop Res 13: 250\u2013257","journal-title":"J Orthop Res"},{"key":"BF02529727_CR22","volume-title":"SAS user's guide: statistics","author":"SAS Institute Inc","year":"1985","unstructured":"SAS Institute Inc (1985) SAS user's guide: statistics, version 5 edition. SAS Institute Inc. Cary, NC","edition":"version 5 editi"},{"key":"BF02529727_CR23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","volume":"322","author":"B Riggs","year":"1990","unstructured":"Riggs B, Hodgson S, O'Fallon W, Chao E (1990) Effect of fluoride treatment on the fracture rate in post-menopausal women with osteoporosis. N Engl J Med 322:802\u2013809","journal-title":"N Engl J Med"},{"key":"BF02529727_CR24","first-page":"139A","volume":"40","author":"P Williams-Russo","year":"1992","unstructured":"Williams-Russo P, Healey JH, Schneider R, Paget SA, Schwartzberg PR (1992) Interobserver consistency in the assessment of vertebral fracture on spine radiographs. Clin Res 40:139A","journal-title":"Clin Res"},{"key":"BF02529727_CR25","unstructured":"Kramer MS, Feinstein AR (1981) The biostatistics of concordance. Clin Pharmacol Ther 11\u2013123"},{"key":"BF02529727_CR26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/art.1780360603","volume":"36","author":"DJ Cook","year":"1993","unstructured":"Cook DJ, Guyatt GH, Adachi JD, et al (1993) Quality of life issues in women with vertebral fracture due to osteoporosis. Arthritis Rheum 36:750\u2013756","journal-title":"Arthritis Rheum"},{"key":"BF02529727_CR27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.53.1.18","volume":"53","author":"H Kroger","year":"1994","unstructured":"Kroger H, Honkanen R, Saarikoskis, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis\u2014a population-based study. Ann Rheum Dis 53:18\u201323","journal-title":"Ann Rheum Dis"},{"key":"BF02529727_CR28","first-page":"557","volume":"11","author":"SM Jones","year":"1993","unstructured":"Jones SM, Bhalla AK (1993) Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 11:557\u2013562","journal-title":"Clin Exp Rheumatol"},{"key":"BF02529727_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0950-3579(05)80298-5","volume":"5","author":"P Guesens","year":"1991","unstructured":"Guesens P, Dequeker J (1991) Locomotor side effects of corticosteroid. Baillieres Clin Rheumatol 5:99\u2013118","journal-title":"Baillieres Clin Rheumatol"},{"issue":"suppl 6","key":"BF02529727_CR30","first-page":"19","volume":"9","author":"BM Ansell","year":"1991","unstructured":"Ansell BM (1991) Overview of the side effects of corticosteroid therapy. Clin Exp Rheumatol 9(suppl 6):19\u201320","journal-title":"Clin Exp Rheumatol"},{"key":"BF02529727_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01623844","volume":"2","author":"IR Reid","year":"1992","unstructured":"Reid IR, Evans MC, Watti DH, Amers R, Cundy TF (1992) Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated patients. Osteoporosis Int 2:103\u2013105","journal-title":"Osteoporosis Int"},{"key":"BF02529727_CR32","first-page":"331","volume-title":"Osteoporosis. Recent advances in pathogenesis and treatment","author":"WSS Jee","year":"1981","unstructured":"Jee WSS, Clark I (1981) Glucocorticoid osteoporosis. In: De Luca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM (eds) Osteoporosis. Recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 331\u2013342"},{"key":"BF02529727_CR33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2500\/108854193778774047","volume":"14","author":"M Schatz","year":"1993","unstructured":"Schatz M, Dudl J, Zeiger RS, et al (1993) Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates. Allergy Proc 14:341\u2013345","journal-title":"Allergy Proc"},{"key":"BF02529727_CR34","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/art.1780361212","volume":"36","author":"AA Kalla","year":"1993","unstructured":"Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36:1726\u20131734","journal-title":"Arthritis Rheum"},{"key":"BF02529727_CR35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/02770909209044799","volume":"29","author":"JR Hollister","year":"1992","unstructured":"Hollister JR (1992) The untoward effects of steroid treatment on the musculoskeletal system and what to do about them [see comments]. J Asthma 29:363\u2013368","journal-title":"J Asthma"},{"key":"BF02529727_CR36","first-page":"278","volume":"26","author":"CK Connolly","year":"1992","unstructured":"Connolly CK, Francis RM, Murthy NK, Prescott RJ, Alcock SM (1992) Steroid-induced bone disease. Conflicting views of respiratory and bone physicians. J R Coll Physicians Lond 26:278\u2013280","journal-title":"J R Coll Physicians Lond"},{"key":"BF02529727_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hon.2900100308","volume":"10","author":"MA Ratcliffe","year":"1992","unstructured":"Ratcliffe MA, Lanham SA, Reid DM, Dawson AA (1992) Bone mineral density (BMD) in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroid and premature menopause. Hematol Oncol 10:181\u2013187","journal-title":"Hematol Oncol"},{"key":"BF02529727_CR38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF00582160","volume":"50L","author":"K Olgaard","year":"1992","unstructured":"Olgaard K, Storm T, van Wowern N, et al (1992) Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort. Calcif Tissue Int 50L:490\u2013497","journal-title":"Calcif Tissue Int"},{"key":"BF02529727_CR39","first-page":"99","volume":"5","author":"G Rizzato","year":"1988","unstructured":"Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosis 5:99\u2013103","journal-title":"Sarcoidosis"},{"key":"BF02529727_CR40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/ajrccm\/142.1.104","volume":"142","author":"M Luengo","year":"1990","unstructured":"Luengo M, Picado C, DelRio L, Guanabens N, Monsterrat JM, Seotain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma: a one-year follow-up study. Am Rev Respir Dis 142:104\u2013107","journal-title":"Am Rev Respir Dis"},{"key":"BF02529727_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0002-9343(93)90057-V","volume":"94","author":"E Shane","year":"1993","unstructured":"Shane E, Del C, Rivas M, Silverberg SJ, Kim TS, Staron RB, Bilezikien JP (1993) Osteoporosis after cardiac transplantation. Am J Med 94:257\u2013264","journal-title":"Am J Med"},{"key":"BF02529727_CR42","first-page":"428","volume":"88","author":"J Loftus","year":"1991","unstructured":"Loftus J, Allen R, Hep R (1991) Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relative bone-sparing effect of deflazacort. Pediatrics 88:428\u2013436","journal-title":"Pediatrics"},{"key":"BF02529727_CR43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.1780340306","volume":"34","author":"RES Gray","year":"1991","unstructured":"Gray RES, Dogherty SM, Galloway J, Coulton L, de Broe M, Kanis JA (1991) A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum 34:287\u2013295","journal-title":"Arthritis Rheum"},{"key":"BF02529727_CR44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00610377","volume":"33","author":"JD Ringe","year":"1987","unstructured":"Ringe JD, Welzel D (1987) Salmon calcitonin in the therapy of corticosteroid-induced osteoporosis. Eur J Clin Pharmacol 33:35\u201339","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02529727_CR45","first-page":"99","volume":"5","author":"G Rizzato","year":"1988","unstructured":"Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin (SCT) in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosis 5:99\u2013103","journal-title":"Sarcoidosis"},{"key":"BF02529727_CR46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/ajrccm\/142.1.104","volume":"142","author":"M Luengo","year":"1990","unstructured":"Luengo M, Picado C, DelRio L, Guanabens N, Montserrat JM, Seotain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma: a one-year follow-up study. Am Rev Respir Dis 142:104\u2013107","journal-title":"Am Rev Respir Dis"},{"key":"BF02529727_CR47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00675619","volume":"52","author":"RFJM Laan","year":"1993","unstructured":"Laan RFJM, Buijs WCAM, van Ering LJTO, et al (1993) Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 52:5\u20139","journal-title":"Calcif Tissue Int"},{"key":"BF02529727_CR48","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/jbmr.5650071014","volume":"7","author":"IR Reid","year":"1992","unstructured":"Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221\u20131225","journal-title":"J Bone Miner Res"},{"issue":"suppl 1","key":"BF02529727_CR49","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/8756-3282(93)90358-H","volume":"14","author":"C Cooper","year":"1993","unstructured":"Cooper C, O'Neill T, Silman A (1993) The epidemiology of vertebral fractures. European Verteral Osteoporosis Study Group. Bone 14(suppl 1):S89-S97","journal-title":"Bone"},{"issue":"suppl 1","key":"BF02529727_CR50","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S8756-3282(09)80007-0","volume":"13","author":"M KleereKoper","year":"1992","unstructured":"KleereKoper M, Nelson DA, Peterson EL, Tilley BC (1992) Outcome variables in osteoporosis trials. Bone 13(suppl 1): S29-S34","journal-title":"Bone"},{"key":"BF02529727_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ajcn\/44.2.287","volume":"44","author":"IR Reid","year":"1986","unstructured":"Reid IR, Ibbertson HK (1986) Calcium supplementation in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 44:287\u2013290","journal-title":"Am J Clin Nutr"},{"issue":"suppl 2","key":"BF02529727_CR52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/32.suppl_2.11","volume":"32","author":"C Gennari","year":"1993","unstructured":"Gennari C (1993) Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol 32(suppl 2): 11\u201314","journal-title":"Br J Rheumatol"},{"key":"BF02529727_CR53","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(88)90566-1","volume":"2","author":"IR Reid","year":"1988","unstructured":"Reid IR, Heap SW, King AR, Ibbertson HK (1988) Two-year follow-up of bisphosphonate (ADP) treatment in steroid-induced osteoporosis. Lancet 2:1144","journal-title":"Lancet"},{"key":"BF02529727_CR54","first-page":"113","volume":"6","author":"JWJ Bijlsma","year":"1988","unstructured":"Bijlsma JWJ, Raymakers JA, Mosch C (1988) Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol 6:113\u2013119","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 1","key":"BF02529727_CR55","first-page":"3A","volume":"52","author":"A Cranney","year":"1993","unstructured":"Cranney A, Adachi JD, Bensen WG, et al (1993) Intermittent cyclic etidronate (ICE) prevents corticosteroid-induced bone loss. Calcif Tissue Int 52(suppl 1):s3A","journal-title":"Calcif Tissue Int"},{"key":"BF02529727_CR56","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","volume":"328","author":"P Sambrook","year":"1993","unstructured":"Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747\u20131752","journal-title":"N Engl J Med"},{"key":"BF02529727_CR57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00308314","volume":"52","author":"SJ Wimalawansa","year":"1993","unstructured":"Wimalawansa SJ (1993) Long- and short-term side effects and safety of calcitonin in man. Calcif Tissue Int 52:90\u201393","journal-title":"Calcif Tissue Int"},{"issue":"suppl 1","key":"BF02529727_CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01621889","volume":"3","author":"P Sambrook","year":"1993","unstructured":"Sambrook P, Birmingham J, Kelly P, et al (1993) Prevention of corticosteroid bone loss. Osteoporosis Int 3(suppl 1):141\u2013143","journal-title":"Osteoporosis Int"},{"key":"BF02529727_CR59","first-page":"173","volume":"316","author":"B Riis","year":"1993","unstructured":"Riis B, Thomsen K, Christiansen C (1993) Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 316:173","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"BF02529727_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01621896","volume":"3","author":"RR Recker","year":"1993","unstructured":"Recker RR (1993) Prevention of osteoporosis: calcium nutrition. Osteoporosis Int 3(suppl 1):163\u2013165","journal-title":"Osteoporosis Int"},{"key":"BF02529727_CR61","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199306173282411","volume":"328","author":"PJ Meunier","year":"1993","unstructured":"Meunier PJ (1993) Is steroid-induced osteoporosis preventable? N Engl J Med 328:1781\u20131782","journal-title":"N Engl J Med"},{"key":"BF02529727_CR62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/bmj.307.6903.519","volume":"307","author":"PN Sambrook","year":"1993","unstructured":"Sambrook PN, Spector TD (1993) Steroid osteoporosis: a pragmatic approach is needed while prospective trials are awaited. Br Med J 307:519\u2013520","journal-title":"Br Med J"},{"key":"BF02529727_CR63","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.1994.03520240070044","volume":"272","author":"NIH Consensus Development Panel on Optimal Calcium Intake","year":"1994","unstructured":"NIH Consensus Development Panel on Optimal Calcium Intake (1994) Optimal calcium intake: NIH Consensus Conference. JAMA 272:1942\u20131948","journal-title":"JAMA"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02529727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02529727\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02529727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T20:55:03Z","timestamp":1558299303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02529727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["BF02529727"],"URL":"https:\/\/doi.org\/10.1007\/bf02529727","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}